Cerevel Therapeutics Holdings Inc (NASDAQ: CERE): Reassessing Prospects
Cerevel Therapeutics Holdings Inc (CERE) concluded trading on Thursday at a closing price of $42.93, with 4.02 million shares of worth about $172.52 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 100.70% during that period and on Thursday the price saw a loss […]
